The data shown below were collected from the profiles of 29 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial
|
---|---|
Published in |
The Lancet Haematology, March 2023
|
DOI | 10.1016/s2352-3026(23)00029-7 |
Pubmed ID | |
Authors |
Christopher Melani, Kennichi Dowdell, Stefania Pittaluga, Kieron Dunleavy, Mark Roschewski, Joo Y Song, Sara Calattini, Jun-Ichi Kawada, David A Price, Pratip K Chattopadhyay, Mario Roederer, Andrea N Lucas, Seth M Steinberg, Elaine S Jaffe, Jeffrey I Cohen, Wyndham H Wilson |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 7% |
France | 2 | 7% |
India | 1 | 3% |
Paraguay | 1 | 3% |
Unknown | 23 | 79% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 18 | 62% |
Scientists | 7 | 24% |
Practitioners (doctors, other healthcare professionals) | 3 | 10% |
Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 16 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 2 | 13% |
Student > Ph. D. Student | 2 | 13% |
Student > Bachelor | 2 | 13% |
Unspecified | 1 | 6% |
Professor > Associate Professor | 1 | 6% |
Other | 0 | 0% |
Unknown | 8 | 50% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 5 | 31% |
Biochemistry, Genetics and Molecular Biology | 1 | 6% |
Unspecified | 1 | 6% |
Neuroscience | 1 | 6% |
Nursing and Health Professions | 1 | 6% |
Other | 0 | 0% |
Unknown | 7 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 289. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 April 2024.
All research outputs
#127,842
of 26,284,763 outputs
Outputs from The Lancet Haematology
#25
of 1,329 outputs
Outputs of similar age
#3,247
of 430,953 outputs
Outputs of similar age from The Lancet Haematology
#3
of 47 outputs
Altmetric has tracked 26,284,763 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,329 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,953 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.